Alnylam Pharmaceuticals (ALNY) Operating Margin Growth (1y) (2010 - 2026)
Alnylam Pharmaceuticals (ALNY) Operating Margin Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 1,997.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,997.00 |
| Dec 31, 2025 | 2,974.00 |
| Sep 30, 2025 | 4,481.00 |
| Jun 30, 2025 | -946.00 |
| Mar 31, 2025 | 1,183.00 |
| Dec 31, 2024 | 874.00 |
| Sep 30, 2024 | -4,385.00 |
| Jun 30, 2024 | 7,947.00 |
| Mar 31, 2024 | 3,813.00 |
| Dec 31, 2023 | 2,982.00 |
| Sep 30, 2023 | 12,612.00 |
| Jun 30, 2023 | 1,316.00 |
| Mar 31, 2023 | 2,189.00 |
| Dec 31, 2022 | 1,896.00 |
| Sep 30, 2022 | -80.00 |
| Jun 30, 2022 | -1,899.00 |
| Mar 31, 2022 | 3,609.00 |
| Dec 31, 2021 | 4,349.00 |
| Sep 30, 2021 | 8,211.00 |
| Jun 30, 2021 | 12,501.00 |